Book a Consultation How It Works Ipamorelin works through selective ghrelin receptor activation, creating clean pulsatile growth hormone release without affecting stress hormones or appetite
Understanding whether you carry variants associated with GLP-1R sensitivity, GIPR signaling, or FTO-driven weight regulation may help provide context for your provider conversation about which GLP-1 option and dosing strategy align with your genetic profile
The regulatory landscape has recently shifted in a manner that heightens the urgency of this work
Payment Processor Scrutiny Is Increasing Its not just the FDA keeping an eye on peptides
Gilead Sciences last year dropped a Phase II (NCT04971785) program to develop the Nimbus-discovered acetyl-CoA Carboxylase (ACC) inhibitor firsocostat (formerly GS-0976 and NDI-010976), in combination with semaglutide and another Gilead candidate, cilofexor, in cirrhosis due to metabolic dysfunction-associated steatohepatitis (MASH)
doi: 10.1590/1414-431x20176472 309 LobbRJvan AmerongenRWiegmansAHamSLarsenJEMllerA
